KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Capital Employed (2017 - 2025)

Biomarin Pharmaceutical's Return on Capital Employed history spans 15 years, with the latest figure at 0.06% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 2.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2025, down 2.0%, and an annual FY2025 reading of 0.06%, down 1.0% over the prior year.
  • Return on Capital Employed for Q4 2025 was 0.06% at Biomarin Pharmaceutical, down from 0.09% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.12% in Q2 2025, with the low at 0.02% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.03% recorded in 2022.
  • Year-over-year, Return on Capital Employed decreased -4bps in 2021 and then grew 7bps in 2025.
  • Tracing BMRN's Return on Capital Employed over 5 years: stood at 0.02% in 2021, then soared by 286bps to 0.03% in 2022, then increased by 18bps to 0.03% in 2023, then skyrocketed by 132bps to 0.08% in 2024, then decreased by -22bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Return on Capital Employed are 0.06% (Q4 2025), 0.09% (Q3 2025), and 0.12% (Q2 2025).